scispace - formally typeset
A

Anne Katrin Schlag

Researcher at King's College London

Publications -  27
Citations -  574

Anne Katrin Schlag is an academic researcher from King's College London. The author has contributed to research in topics: Cannabis & Medicine. The author has an hindex of 7, co-authored 18 publications receiving 284 citations. Previous affiliations of Anne Katrin Schlag include Imperial College London.

Papers
More filters
Journal ArticleDOI

Ketamine treatment for depression: opportunities for clinical innovation and ethical foresight

TL;DR: It is found that, based on current evidence, ketamine use for severe, treatment-resistant depression does not violate ethical principles; however, clinicians and professional bodies must take steps to ensure that guidelines for good practice are enacted and that the risk potential of ketamine treatment continues to be monitored and modelled.
Journal ArticleDOI

Aquaculture: an emerging issue for public concern

TL;DR: It is argued that aquaculture incorporates a range of issues, which have already been shown to be a catalyst for public concern and requires a social science approach in order to be able to anticipate and address future controversies in a timely and efficient manner.
Journal ArticleDOI

Europeans and aquaculture: perceived differences between wild and farmed fish

TL;DR: In this article, the authors compared consumer perceptions of the production and consumption of wild and farmed fish in seven European countries: France, Italy, Germany, Greece, Norway, Spain and the UK.
Journal ArticleDOI

Adverse effects of psychedelics: From anecdotes and misinformation to systematic science

TL;DR: The review shows that medical risks are often minimal, and that many – albeit not all – of the persistent negative perceptions of psychological risks are unsupported by the currently available scientific evidence, with the majority of reported adverse effects not being observed in a regulated and/or medical context.
Journal ArticleDOI

An Evaluation of Regulatory Regimes of Medical Cannabis: What Lessons Can Be Learned for the UK?

TL;DR: Six countries that have been at the forefront of prescribing medical cannabis are looked at, including case studies of the three largest medical cannabis markets in the EU: Germany, Italy, and the Netherlands.